Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion type Assertion NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_head.
- NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_provenance.
- NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion evidence source_evidence_literature NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_provenance.
- NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion SIO_000772 21799180 NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_provenance.
- NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion wasDerivedFrom befree-20140225 NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_provenance.
- NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion wasGeneratedBy ECO_0000203 NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_provenance.